* Cardlytics Inc CDLX.OQ CDLX.O is expected to show a
rise in
quarterly revenue when it reports results on November 1.
* The Atlanta Georgia-based company is expected to report
a
13.7% increase in revenue to $73.898 million from $64.98 million
a year ago, according to the mean estimate from 6 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Cardlytics Inc is
for a
loss of 57 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and 2 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Cardlytics
Inc is
$15, above its last closing price of $9.73.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 -0.42 -0.47 -0.65 Missed -38.9
Mar. 31 2022 -0.52 -0.55 -0.38 Beat 31.3
Dec. 31 2021 -0.36 -0.42 -0.15 Beat 63.9
Sep. 30 2021 -0.52 -0.54 -0.33 Beat 38.9
Jun. -0.38 -0.39 -0.39 Met -0.9
30 2021
Mar. 31 2021 -0.44 -0.34 -0.34 Met -0.6
Dec. 31 2020 -0.04 -0.03 -0.05 Missed -92.3
Sep. 30 2020 -0.28 -0.28 -0.16 Beat 42.9
This summary was machine generated October 29 at 00:04 GMT. All
figures in US dollars unless otherwise stated